Skip to main content

Table 1 Comparisons of patient characteristics

From: CT-based radiomics models may predict the early efficacy of microwave ablation in malignant lung tumors

Characteristics

Effective treatment cohort

Ineffective treatment cohort

p value

Age, year

63.27 ± 10.73

69.38 ± 10.05

0.010*

Gender

  

0.096

Male

49 (47.1%)

17 (65.4%)

 

Female

55 (52.9%)

9 (34.6%)

 

Tumor pathology

  

0.387

Primary

20 (19.2%)

7 (26.9%)

 

Metastasis

84 (80.8%)

19 (73.1%)

 

Tumor indicators

  

0.927

Absent

37 (35.6%)

17 (65.4%)

 

Present

67 (64.4%)

9 (34.6%)

 

Systematic treatment

  

0.093

Absent

66 (63.4%)

21 (80.8%)

 

Present

38 (36.5%)

5 (19.2%)

 

Tumor Size

12.50 (9.03, 17.15)

20.05 (12.53, 31.83)

<0.001*

Minimum GGO margin depth

5.93 ± 1.98

4.78 ± 1.82

0.008*

Maximum GGO margin depth

11.95 (9.75, 15.88)

11.30 (8.38, 15.73)

0.331

Density

  

0.558

Solid

89 (85.6%)

24 (92.3%)

 

Non-Solid

15 (14.4%)

2 (7.7%)

 

Location

  

0.725

Upper middle lobe

56 (53.8%)

13 (50.0%)

 

Lower lobe

48 (46.2%)

13 (50.0%)

 

Adjacent large blood vessels

  

0.088

Absent

67 (64.4%)

12 (46.2%)

 

Present

37 (35.6%)

14 (53.8%)

 

Adjacent large bronchus

  

0.001*

Absent

96 (92.3%)

17 (65.4%)

 

Present

8 (7.7%)

9 (34.6%)

 

Margin

  

0.065

Smooth

72 (69.2%)

13 (50.0%)

 

Rough

32 (30.8%)

13 (50.0%)

 

Pleural pull

  

0.170

Absent

26 (25.0%)

16 (61.5%)

 

Present

78 (75.0%)

10 (38.5%)

 
  1. p-value reflected the differences between the effective treatment and ineffective treatment cohort, *p < 0.05 (two-sided) was considered statistically significant. Minimum (Maximum) GGO margin depth refers to the minimum (maximum) distance between the tumor margin and the ablation zone margin